Stock HOLX HOLOGIC, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Hologic, Inc.

Equities

HOLX

US4364401012

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
75.14 USD -0.81% Intraday chart for Hologic, Inc. -1.83% +5.16%
May. 09 Argus Adjusts Price Target on Hologic to $95 From $89 MT
May. 06 Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6% MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Argus Adjusts Price Target on Hologic to $95 From $89
MT
Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6%
MT
JPMorgan Adjusts Price Target on Hologic to $91 From $85
MT
UBS Adjusts Price Target on Hologic to $81 From $79, Maintains Neutral Rating
MT
Hologic : Second Quarter Fiscal 2024 Earnings Conference Call Transcript
PU
Hologic : Second Quarter 2024 Transcript
PU
Hologic : Second Quarter 2024 Prepared Remarks
PU
Hologic Fiscal Q2 Earnings, Revenue Decline; Q3 Outlook Issued, Fiscal 2024 Estimates Revised -- Shares Up After Hours
MT
Transcript : Hologic, Inc., Q2 2024 Earnings Call, May 02, 2024
Hologic: Fiscal Q2 Earnings Snapshot
AQ
Earnings Flash (HOLX) HOLOGIC Posts Q2 EPS $1.03, vs. Street Est of $0.98
MT
Earnings Flash (HOLX) HOLOGIC Reports Q2 Revenue $1.02B, vs. Street Est of $1B
MT
(HOLX) HOLOGIC Expects Fiscal Year 2024 EPS Range $4.02 - $4.12
MT
(HOLX) HOLOGIC Sees Q3 EPS Range $0.98 - $1.05
MT
Hologic Announces Financial Results for Second Quarter of Fiscal 2024
BU
Hologic, Inc. Reports Impairment of Intangible Assets for the Second Quarter Ended March 30, 2024
CI
Hologic, Inc. Revises Earnings Guidance for the Fiscal Year 2024
CI
Hologic, Inc. Provides Earnings Guidance for the Third Quarter of Fiscal 2024
CI
Hologic, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 30, 2024
CI
Hologic : Statement on USPSTF Final Breast Cancer Screening Guidelines
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HOLX Stock
  4. News Hologic, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW